𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumor

✍ Scribed by Akira Sawaki; Toshirou Nishida; Toshihiko Doi; Yasuhide Yamada; Yoshito Komatsu; Tatsuo Kanda; Yoshihiro Kakeji; Yusuke Onozawa; Makoto Yamasaki; Atsushi Ohtsu


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
263 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES